¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"clear plaque mutation"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
¼³¸í
mottled plaque
¿ë±Õ ¹Ý
opaline plaque
´Ü¹é¼®¾ç ¹Ý
plaque control
ġŠÁ¶Àý
plaque formation
º´¼Ò ¹Ý Çü¼º, ÇöóÅ© Çü¼º
ȹµæ ÇǸ·ÀÇ Çü¼º, ȹµæ ÇǸ·¿¡ ¼¼±ÕÀÇ ÃʱâºÎÂø, ¼¼±Õ¼º ġŰ¡ ¸î ÃþÀ¸·Î ÃàÀûµÇ¾î µÎ²¨¿öÁö´Â °úÁ¤À» ¸»ÇÑ´Ù.
plaque forming unit
ÇöóÅ© Çü¼º ´ÜÀ§
plaque like
¹ÝÁ¡ °°Àº
plaque like lesion
¹ÝÁ¡ °°Àº º´¼Ò
plaque-like
¹ÝÁ¡Çü, ¹ÝÇü
scleroderma in plaque
ġų» °øÇÇÁõ
amber mutation
¾Ïº£¸£ µ¹¿¬º¯ÀÌ
auxotrophic mutation
¿µ¾ç ¿ä±¸ µ¹¿¬º¯ÀÌ
biochemical mutation
»ýÈÇÐÀû µ¹¿¬º¯ÀÌ
cold-sensitive mutation
ÇÑ·© ¹Î°¨¼º µ¹¿¬º¯ÀÌ
conditional mutation
Á¶°ÇºÎ µ¹¿¬º¯ÀÌ
constitutive mutation
±¸¼ºÀû µ¹¿¬º¯ÀÌ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½